EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:87209 - virginiamycin
| ChEBI ID | CHEBI:87209 |
| ChEBI Name | virginiamycin |
| Stars | |
| Definition | A mixture of cyclic polypeptide streptogramin antibiotics produced by Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. The two major components are virginiamycin M1 (also known as pristinamycin IIA) and virginiamycin S1. Virginiamycin has been widely used as a growth promotion agent in livestock and has been to have bacteriostatic activity against Gram-positive organisms such as staphylococci and streptococci. |
| Last Modified | 3 August 2015 |
| Submitter | Kevin |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. antibacterial drug A drug used to treat or prevent bacterial infections. |
| Application: | antibacterial drug A drug used to treat or prevent bacterial infections. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| virginiamycin (CHEBI:87209) has part pristinamycin IIA (CHEBI:9997) |
| virginiamycin (CHEBI:87209) has part virginiamycin S1 (CHEBI:46416) |
| virginiamycin (CHEBI:87209) has role antibacterial drug (CHEBI:36047) |
| virginiamycin (CHEBI:87209) has role bacterial metabolite (CHEBI:76969) |
| virginiamycin (CHEBI:87209) is a mixture (CHEBI:60004) |
| INNs | Source |
|---|---|
| virginiamycin | WHO MedNet |
| virginiamicina | WHO MedNet |
| virginiamycinum | WHO MedNet |
| virginiamycine | WHO MedNet |
| Synonym | Source |
|---|---|
| virginiamycins | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| Virginiamycin | Wikipedia |
| D06311 | KEGG DRUG |
| HMDB0030520 | HMDB |
| Registry Numbers | Sources |
|---|---|
| Reaxys:13135027 | Reaxys |
| CAS:11006-76-1 | ChemIDplus |
| CAS:11006-76-1 | KEGG DRUG |
| Citations |
|---|